Showing results (31-40 of 107) with videos related to
Sort By:
Pageof 11
American Journal of Clinical Oncology|June 1, 2004
Adriamycin and cis-platinum as first-line treatment in unresectable locally advanced or metastatic adult soft-tissue sarcomasHaralabos P Kalofonos, Dimitrios Bafaloukos, Theodoros G Kourelis, et al.Breast (Edinburgh, Scotland)|November 28, 2015
Hormonal receptor status, Ki-67 and HER2 expression: Prognostic value in the recurrence of ductal carcinoma in situ of the breast?Nikiforita Poulakaki, Georgios-Marios Makris, Marco-Johannes Battista, et al.Cancer Medicine|December 10, 2015
Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trialsAgnieszka Malczewski, Andrea Marshall, Miranda J Payne, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 25, 2006
Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II studyPavlos Papakostas, Dimitrios Tsavdaridis, Paris Kosmidis, et al.Anticancer Research|January 4, 2012
Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2Paris A Kosmidis, Konstantinos Syrigos, Haralampos P Kalofonos, et al.Clinical Breast Cancer|May 26, 2010
Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology GroupHelen Gogas, Dimitrios Pectasides, Ioannis Kostopoulos, et al.Critical Reviews in Oncology/Hematology|February 5, 2008
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictorsGeorge Pentheroudakis, George Fountzilas, Haralabos P Kalofonos, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology GroupParis A Kosmidis, Meletios-Athanasios Dimopoulos, Konstantinos Syrigos, et al.Anticancer Research|July 28, 2004
Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group studyHelen Gogas, Dimitrios Bafaloukos, John Ioannovich, et al.Plos One|January 30, 2014
A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferonPetr Pancoska, John M Kirkwood, Spyros Bouros, et al.Pageof 11